Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Cardiometabolic Diseases | Biopharma |
Description | Leader in Cardiovascular Developing new treatments for various cardiometabolic diseases is what we do best at CVI Pharmaceuticals Limited, a clinical-stage biopharma |
Keywords | cardiometabolic diseases |
WebSite | cvipharma.com |
Host IP | 66.175.58.9 |
Location | United States |
Site | Rank |
US$405,605
Last updated: 2023-05-18 09:24:00
cvipharma.com has Semrush global rank of 26,095,153. cvipharma.com has an estimated worth of US$ 405,605, based on its estimated Ads revenue. cvipharma.com receives approximately 46,801 unique visitors each day. Its web server is located in United States, with IP address 66.175.58.9. According to SiteAdvisor, cvipharma.com is safe to visit. |
Purchase/Sale Value | US$405,605 |
Daily Ads Revenue | US$375 |
Monthly Ads Revenue | US$11,233 |
Yearly Ads Revenue | US$134,786 |
Daily Unique Visitors | 3,121 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
cvipharma.com. | A | 21600 | IP: 66.175.58.9 |
cvipharma.com. | NS | 21600 | NS Record: dns3.earthlink.net. |
cvipharma.com. | NS | 21600 | NS Record: dns1.earthlink.net. |
cvipharma.com. | NS | 21600 | NS Record: dns2.earthlink.net. |
cvipharma.com. | MX | 21600 | MX Record: 10 mx1c38.carrierzone.com. |
cvipharma.com. | MX | 21600 | MX Record: 100 mx2c38.carrierzone.com. |
cvipharma.com. | MX | 21600 | MX Record: 110 mx3c38.carrierzone.com. |
cvipharma.com. | MX | 21600 | MX Record: 120 mx4c38.carrierzone.com. |
cvipharma.com. | TXT | 21600 | TXT Record: v=spf1 a mx include:spfc38.carrierzone.com include:verticalresponse.com ~all |
info@cvipharma.com Menu Home About Us Our Pipeline Investors and news Contact Us C ardio V ascular I nnovation New Biopharmaceutical Products At CVI Pharmaceuticals Limited, we never cease in discovering Leading Healthcare Investors CVI Pharmaceuticals Limited works with various healthcare investors Contact Our Biopharmaceutical Company Make CVI Pharmaceuticals Limited your trusted biopharmaceutical firm. Leader in Cardiovascular Innovation Developing Treatments for Hypercholesterolemia and NAFLD/NASH For more than 10 years, CVI has been addressing the unique and unprecedented unmet needs in cardiometabolic diseases through innovative therapeutics. Our clinical-stage biopharma company is focused on developing new, first-in-class, small-molecule oral therapies that can help treat hypercholesterolemia, nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), obesity, and rare metabolic diseases. Inquire About Our Cholesterol-Lowering Medications Make CVI |
HTTP/1.1 200 OK Date: Fri, 10 Jun 2022 04:32:51 GMT Content-Type: text/html; charset=UTF-8 Connection: keep-alive Vary: Accept-Encoding p3p: CP="CAO PSA CONi OTRo OUR ONL" Set-Cookie: flsession=1654835569_543298_1165054762; path=/ Access-Control-Allow-Origin: https://img-fl.nccdn.net Access-Control-Allow-Methods: GET Access-Control-Allow-Headers: accept, x-request, x-requested-with Strict-Transport-Security: max-age=31536000; includeSubDomains X-Content-Type-Options: nosniff Content-Security-Policy: default-src * data: blob: 'unsafe-eval' 'unsafe-inline'; object-src 'none'; |
Domain Name: CVIPHARMA.COM Registry Domain ID: 752214529_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.tucows.com Registrar URL: http://www.tucows.com Updated Date: 2022-01-12T08:31:10Z Creation Date: 2007-01-12T16:49:19Z Registry Expiry Date: 2023-01-12T16:49:19Z Registrar: Tucows Domains Inc. Registrar IANA ID: 69 Registrar Abuse Contact Email: domainabuse@tucows.com Registrar Abuse Contact Phone: +1.4165350123 Domain Status: ok https://icann.org/epp#ok Name Server: DNS1.EARTHLINK.NET Name Server: DNS2.EARTHLINK.NET Name Server: DNS3.EARTHLINK.NET DNSSEC: unsigned >>> Last update of whois database: 2022-06-04T11:20:53Z <<< |